These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8832109)

  • 1. Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.
    Morvillo V; Bover L; Mordoh J
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):779-95. PubMed ID: 8832109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
    Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
    J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta is not the major soluble immunosuppressor in the microenvironments of human breast tumours.
    Xie J; Gallagher G
    Anticancer Res; 1992; 12(6B):2117-21. PubMed ID: 1295457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunization of human B lymphocytes with cultured melanoma cells (SK-MEL 28).
    Zhang XM; Borrebaeck CA
    Hum Antibodies Hybridomas; 1990; 1(1):42-6. PubMed ID: 1966473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of interleukin 2 production by factors released from tumor cells.
    Hersey P; Bindon C; Czerniecki M; Spurling A; Wass J; McCarthy WH
    J Immunol; 1983 Dec; 131(6):2837-42. PubMed ID: 6605993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of lymphokine-activated killer cells generation in vitro by soluble factors released from mixed human tumor and peripheral blood mononuclear adherent cells culture.
    Eisenthal A; Barbarsteyn E; Gitstein G; Lifschitz-Mercer B
    Cancer Invest; 2006 Feb; 24(1):28-34. PubMed ID: 16466989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemokine RANTES is secreted by human melanoma cells and is associated with enhanced tumour formation in nude mice.
    Mrowietz U; Schwenk U; Maune S; Bartels J; Küpper M; Fichtner I; Schröder JM; Schadendorf D
    Br J Cancer; 1999 Mar; 79(7-8):1025-31. PubMed ID: 10098731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
    Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
    Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG; Castelli C; Maeurer MJ; Squarcina P; Cova A; Pilla L; Renkvist N; Parmiani G; Rivoltini L
    Cancer Res; 2003 Apr; 63(7):1560-7. PubMed ID: 12670905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma.
    Elg SA; Mayer AR; Carson LF; Twiggs LB; Hill RB; Ramakrishnan S
    Cancer; 1997 Oct; 80(8):1448-56. PubMed ID: 9338469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic resistance: characterization and inactivation by specific antiserum of a putative protein family produced by tumour cells.
    Zhou S; Li W; Hill HZ; Hill GJ; Kueppers F; McKenna WG; Muschel RJ; Wolansky LJ; Silva HC
    Melanoma Res; 1999 Feb; 9(1):40-50. PubMed ID: 10338333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.
    Tamura K; Shibata Y; Matsuda Y; Ishida N
    Cancer Res; 1981 Aug; 41(8):3244-52. PubMed ID: 6166371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification with monoclonal antibody 140.240 of a structural variant of melanotransferrin shed by human melanoma cell lines in vitro.
    Liao SK
    Anticancer Res; 1996; 16(1):171-6. PubMed ID: 8615605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII concentrates and the immune system--laboratory investigations.
    Wadhwa M; Barrowcliffe TW; Mire-Sluis AR; Thorpe R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S65-79. PubMed ID: 7495973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis.
    Jenne L; Arrighi JF; Jonuleit H; Saurat JH; Hauser C
    Cancer Res; 2000 Aug; 60(16):4446-52. PubMed ID: 10969791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.